J. Verhaeghe et al., DECREASED OSTEOBLAST ACTIVITY IN SPONTANEOUSLY DIABETIC RATS - IN-VIVO STUDIES ON THE PATHOGENESIS, ENDOCRINE, 7(2), 1997, pp. 165-175
Diabetes in both humans and rats is accompanied by low bone formation,
which is presumably caused by serum-borne factors. To explore its pat
hogenesis, we carried out experiments in diabetic and nondiabetic BB r
ats, using plasma osteocalcin concentrations (OC) as a marker for oste
oblast activity. In nondiabetic rats, the iv infusion of glucose (30%,
4 d) did not change OC; sc insulin infusion (4 U/d, 14 d) reduced OC
by 27% (p < 0.01). In diabetic rats, OC were decreased from the first
day of glycosuria (71 +/- 5% of paired controls), declining exponentia
lly to 24 +/- 3% after 5 wk. Insulin infusion (1,2, and 3 U/d, 14 d) p
roduced gradual restoration of OC. OC were better correlated with insu
lin-like growth factor-I (IGF-I) than with insulin levels in these exp
eriments. OC were dramatically increased 4 d after adrenalectomy (ADX)
in all diabetic rats (73 +/- 8 vs 22 +/- 4 mu g/L before ADX; p < 0.0
01), but not if corticosterone was administered. Ligand blotting of IG
F binding proteins showed a marked decrease in two bands (44-49 and 32
-35 kDa) 10-14 d after diabetes onset; the density of these bands was
increased, but not normalized after ADX. Thus, decreased osteoblast ac
tivity is present from the onset of diabetes, is dependent on endogeno
us corticosterone, and cannot be reproduced by hyperglycemia in nondia
betic rats.